CERRI, Stefania
 Distribuzione geografica
Continente #
NA - Nord America 10.753
EU - Europa 8.699
AS - Asia 1.695
SA - Sud America 52
OC - Oceania 17
AF - Africa 15
Continente sconosciuto - Info sul continente non disponibili 11
Totale 21.242
Nazione #
US - Stati Uniti d'America 10.697
IT - Italia 4.372
GB - Regno Unito 1.951
SE - Svezia 681
CN - Cina 562
DE - Germania 500
SG - Singapore 302
FR - Francia 295
HK - Hong Kong 276
UA - Ucraina 268
TR - Turchia 198
FI - Finlandia 179
BG - Bulgaria 125
IN - India 66
ID - Indonesia 65
JP - Giappone 62
RU - Federazione Russa 61
IE - Irlanda 55
KR - Corea 41
VN - Vietnam 41
BE - Belgio 39
CA - Canada 34
RO - Romania 31
NL - Olanda 23
ES - Italia 21
PK - Pakistan 20
BR - Brasile 19
MX - Messico 18
IR - Iran 16
LT - Lituania 14
TW - Taiwan 14
CH - Svizzera 12
PL - Polonia 12
MY - Malesia 11
AR - Argentina 10
AU - Australia 10
CZ - Repubblica Ceca 9
EU - Europa 8
AL - Albania 7
CL - Cile 7
NZ - Nuova Zelanda 7
AT - Austria 6
CO - Colombia 6
EG - Egitto 6
SA - Arabia Saudita 6
GR - Grecia 5
LV - Lettonia 5
NO - Norvegia 5
PE - Perù 5
ZA - Sudafrica 5
HR - Croazia 4
IQ - Iraq 4
LU - Lussemburgo 4
BZ - Belize 3
DK - Danimarca 3
HU - Ungheria 3
TH - Thailandia 3
TN - Tunisia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
IL - Israele 2
KZ - Kazakistan 2
PT - Portogallo 2
RS - Serbia 2
VE - Venezuela 2
A1 - Anonimo 1
AD - Andorra 1
AZ - Azerbaigian 1
BO - Bolivia 1
CU - Cuba 1
EC - Ecuador 1
EE - Estonia 1
JO - Giordania 1
MA - Marocco 1
MM - Myanmar 1
PH - Filippine 1
PY - Paraguay 1
SI - Slovenia 1
SM - San Marino 1
VA - Santa Sede (Città del Vaticano) 1
Totale 21.242
Città #
Fairfield 1.687
Southend 1.635
Woodbridge 987
Chandler 947
Ashburn 928
Houston 735
Seattle 602
Wilmington 532
Cambridge 515
Dearborn 469
Nyköping 444
Ann Arbor 443
Jacksonville 424
Milan 295
Rome 270
Hong Kong 264
Singapore 200
Modena 191
Beijing 176
San Diego 172
New York 141
Princeton 123
Sofia 123
Helsinki 107
Eugene 105
Naples 100
Palermo 91
Izmir 90
Florence 89
Redwood City 83
Bologna 72
Jakarta 61
London 59
Bari 56
Bremen 56
Catania 55
Tokyo 47
Boardman 46
Turin 46
Shanghai 45
Dong Ket 36
Phoenix 35
Brussels 32
Dublin 32
Padova 31
Genoa 30
Reggio Emilia 27
Falls Church 26
Mountain View 26
Munich 26
Norwalk 26
Verona 26
Cagliari 25
Grafing 22
Guangzhou 22
Timisoara 21
Chicago 20
Parma 20
Brescia 19
Frankfurt am Main 19
Salerno 19
Pescara 18
Bergamo 17
Hefei 17
San Jose 17
Nanjing 16
San Francisco 16
Treviso 16
Venice 16
Lahore 15
Los Angeles 15
Perugia 15
Ottawa 14
Trieste 14
Berlin 13
Chiswick 13
Jinan 13
Monza 13
Ankara 12
Leawood 12
Messina 12
Saint Petersburg 12
Kilburn 11
Torino 11
Kunming 10
Menlo Park 10
Napoli 10
Reggio Nell'emilia 10
Siena 10
São Paulo 10
Cinisello Balsamo 9
Holly 9
Hounslow 9
Livorno 9
Nonantola 9
Pisa 9
Pistoia 9
San Mateo 9
Seongnam 9
Taipei 9
Totale 14.529
Nome #
INTERSTIZIOPATIA POLMONARE NON CLASSIFICABILE O SECONDARIA A CONNETTIVITE INDIFFERENZIATA. IMPORTANZA E DIFFICOLTÀ DI UNA DIAGNOSI DIFFERENZIALE. 2.999
Malattie infiltrative diffuse del polmone 757
Multidrug-resistant tuberculosis outbreak in an Italian prison: Tolerance of pyrazinamide plus levofloxacin prophylaxis and serial interferon gamma release assays 670
Non-steroid agents for idiopathic pulmonary fibrosis 267
Diagnostic accuracy of a velcro sound detector (VECTOR) for interstitial lung disease in rheumatoid arthritis patients: The InSPIRAtE validation study (INterStitial pneumonia in rheumatoid ArThritis with an electronic device) 261
Structured reporting for fibrosing lung disease: a model shared by radiologist and pulmonologist 259
Analysis of pulmonary sounds for the diagnosis of interstitial lung diseases secondary to rheumatoid arthritis 251
Radiologic classification of usual interstitial pneumonia in rheumatoid arthritis-related interstitial lung disease: correlations with clinical, serological and demographic features of disease 241
Effectiveness of pulmonary rehabilitation in patients with INTERSTITIAL LUNG DISEASE of different etiology: a multicenter prospective study 232
Levels of circulating endothelial cells are low in idiopathic pulmonary fibrosis and are further reduced by anti-fibrotic treatments 225
Predictive value of isolated DLCO reduction in systemic sclerosis patients without cardio-pulmonary involvement at baseline 222
Pretreatment rate of decay in forced vital capacity predicts long-term response to pirfenidone in patients with idiopathic pulmonary fibrosis. 218
Diagnosis of occult tuberculosis in hematological malignancy by enumeration of antigen-specific T cells. 217
Acute exacerbation of Idiopathic Pulmonary Fibrosis: lessons learned from the Acute Respiratory Distress Syndrome 217
"Velcro-type" crackles predict specific radiologic features of fibrotic interstitial lung disease 217
Use of Pirfenidone in Idiopathic Pulmonary Fibrosis: A Case Study 210
Combination Therapy with Nintedanib and Sarilumab for the Management of Rheumatoid Arthritis Related Interstitial Lung Disease 209
NEW PERSPECTIVES IN DIAGNOSIS OF INTERSTITIAL LUNG DISEASE RELATED TO RHEUMATOID ARTHRITIS. VALIDATION STUDY OF AN ELECTRONIC STETHOSCOPE AND AD HOC SOFTWARE FOR DETECTION OF PULMONARY CRACKLES 207
Ventilatory support and mechanical properties of the fibrotic lung acting as a “squishy ball” 197
Occurrence of idiopathic pulmonary fibrosis during immunosuppressive treatment: a case report 188
Acute exacerbation of idiopathic pulmonary fibrosis: a clinical review 186
Lung cancer in scleroderma: results from an Italian rheumatologic center and review of the literature. 186
Prevalence and clinical significance of circulating autoantibodies in idiopathic pulmonary fibrosis 184
Role Of The QFT-IT Assay For The Diagnosis Of Latent Tuberculosis Infection Among Adult Immigrants 183
Acute exacerbation of interstitial lung diseases secondary to systemic rheumatic diseases: A prospective study and review of the literature 180
Interstitial pneumonia with autoimmune features and undifferentiated connective tissue disease: Our interdisciplinary rheumatology-pneumology experience, and review of the literature 179
Subclinical liver fibrosis in patients with idiopathic pulmonary fibrosis 179
Comparison of the tubercolin skin test and the ellispot blood test for the diagnosis of latent tuberculosis infection in pre-transplant dialysis patients 178
A quantitative proteomic approach to identify significantly altered protein networks in the serum of patients with lymphangioleiomyomatosis (LAM) 177
New approaches to the design of clinical trials in idiopathic pulmonary fibrosis 177
Pulmonary fibrosis and the many faces of UIP 177
Rifabutin for treating pulmonary tuberculosis. 173
Mindfulness-based stress reduction in patients with interstitial lung diseases: a pilot, single-centre observational study on safety and efficacy 173
Prevalence and characterization of non-sicca onset primary Sjögren syndrome with interstitial lung involvement 171
Tocilizumab therapy in rheumatoid arthritis with interstitial lung disease: a multicenter retrospective study 171
The encaged lung: rapidly progressive idiopathic pleurisy. 170
Lung fibrosis, bone marrow fibrosis and liver cirrhosis: A Short Telomere Syndrome or a casual association? 168
Using ELISpot technology to improve the diagnosis of tuberculosis infection: from the bench to the T-SPOT.TB assay 167
Pulmonary Carcinosarcoma Arising in the Framework of an Idiopathic Pulmonary Fibrosis 167
Best supportive care for idiopathic pulmonary fibrosis: Current gaps and future directions 166
Janus-faced amiodarone-induced pneumopathy 166
Clinical differences in sarcoidosis patients with and without lymphoma: a single-center retrospective cohort analysis. 165
Management of Idiopathic Pulmonary Fibrosis 163
Smoking-related interstitial lung disease 159
Emerging drugs for idiopathic pulmonary fibrosis. 159
Quantiferon-TB Gold In-Tube Tests In Hospital Health Care Workers: A Five Years Experience 159
Management of idiopathic pulmonary fibrosis. 159
Sarcoidosis: challenging diagnostic aspects of an old disease. 158
Ultrasound assessed Diaphragm Impairment is a Predictor of Outcomes in Acute Exacerbation of Chronic Obstructive Pulmonary Disease undergoing Non-Invasive Ventilation. 155
HRCT Patterns Of Usual Interstitial Pneumonia In Rheumatoid Lung 155
The big clinical trials in idiopathic pulmonary fibrosis. 153
A Real-Life Multicenter National Study on Nintedanib in Severe Idiopathic Pulmonary Fibrosis 153
Serial Ultrasound Assessment of Diaphragmatic Function and Clinical Outcome in Patients with Amyotrophic Lateral Sclerosis. 153
Home Oxygen Saturation Monitoring And Quality Of Life Evaluation In Patients With Idiopathic Pulmonary Fibrosis: Preliminary Results From A Prospective Multicenter Trial 152
INTERSTITIAL LUNG DISEASE RELATED TO RHEUMATOID ARTHRITIS. WHAT DO WE DON’T KNOW? THE LIRA STUDY (LUNG INVOLVEMENT IN RHEUMATOID ARTHRITIS) 152
UNCLASSIFIABLE INTERSTITIAL LUNG DISEASE OR UNDIFFERENTIATED CONNECTIVE TISSUE DISEASE? A CHALLENGING DIFFERENTIAL DIAGNOSIS 151
The performance of the GAP model in patients with rheumatoid arthritis associated interstitial lung disease 150
Human mucosal associated invariant T cells detect bacterially infected cells 147
Empoyment of the ELISPOT blood test for the diagnosis of latent tuberculosis infection in dialysis patients awaiting renal transplantation 147
Repeated Quantiferon-TB Gold In-Tube Tests In Routine Clinical Practice: A Five Years Experience 145
Performance of tests for latent tuberculosis in different groups of immunocompromised patients 144
Genetic commonality between inflammatory bowel disease and sarcoidosis: the beginning of the end or the end of the beginning? 144
Prevalence Of Subclinical Liver Fibrosis Among Patients With Idiopathic Pulmonary Fibrosis 143
AB1157 VALIDATION OF VECTOR (VELCRO CRACKLES DETECTOR) FOR THE DIAGNOSIS OF INTERSTITIAL LUNG DISEASE IN PATIENTS WITH CONNECTIVE TISSUE DISEASES 143
Real-life comparison of Pirfenidone and Nintedanib in patients with Idiopathic Pulmonary Fibrosis: a 24-month assessment. 142
Genetic testing in diffuse parenchymal lung disease 141
Proteomics Analysis of Formalin-Fixed Paraffine-Embedded Tissue Reveals Key Proteins Related to Lung Dysfunction in Idiopathic Pulmonary Fibrosis. 138
Fibulin-1 predicts disease progression in patients with idiopathic pulmonary fibrosis 135
RHEUMATOID ARTHRITIS RELATED INTERSTITIAL LUNG DISEASE. RADIOLOGICAL PATTERNS AND CORRELATIONS WITH CLINICAL, SEROLOGICAL AND DEMOGRAPHIC FEATURES OF DISEASE 132
Antifibrotic treatment response and prognostic predictors in patients with idiopathic pulmonary fibrosis and exposed to occupational dust 132
Interstitial pneumonia with autoimmune features: A single center prospective follow-up study 132
Therapeutic Options for the Treatment of Interstitial Lung Disease Related to Connective Tissue Diseases. A Narrative Review 132
Efficacy of pirfenidone for idiopathic pulmonary fibrosis: An Italian real life study 130
Interstitial lung disease is associated to infections of lower respiratory tract in immunocompromised rheumatoid arthritis patients 128
Inappropriatezza prescrittiva dell'ossigenoterapia domiciliare a lungo termine 127
Impact of a T cell-based blood test for tuberculosis infection on clinical decision-making in routine practice 124
Molecular mechanisms and cellular contribution from lung fibrosis to lung cancer development. 124
INTERSTITIAL LUNG DISEASE IS ASSOCIATED TO INFECTIONS OF LOWER RESPIRATORY TRACT IN IMMUNOCOMPROMISED RHEUMATOID ARTHRITIS PATIENTS 123
Corticosteroid and immunomodulatory agents in idiopathic pulmonary fibrosis 122
Unusual effectiveness of systemic steroids in Whipple disease. 122
Morbidity and Mortality in Patients with Idiopathic Pulmonary Fibrosis Undergoing Diagnostic Surgical Lung Biopsy 121
AB0472 PRIMARY SJOGREN SYNDROME ASSOCIATED INTERSTITIAL LUNG DISEASE: FEATURES, TREATMENT AND OUTCOME OF A MONOCENTRIC COHORT 121
The prognostic role of Gender-Age-Physiology system in idiopathic pulmonary fibrosis patients treated with pirfenidone 119
Challenges in idiopathic interstitial lung disease 118
Tubercolosi 117
Validation of a Method for Automatic Detection of Lung Sounds in Fibrotic Interstitial Lung Disease 115
Do not forget to assess the muscle integrity in COPD patients. 114
Predictive Value of DLCO Reduction in Scleroderma Patients Without Cardio-Pulmonary Involvement at Baseline 112
Sindrome di Goodpasture 111
Pulmonary stretch and lung mechanotransduction: Implications for progression in the fibrotic lung 110
Pneumologia 109
Pirfenidone for the treatment of interstitial lung disease associated to rheumatoid arthritis: a new scenario is coming? 108
Identification Of Potential Candidate Biomarkers In Lymphangioleiomyomatosis Using ITRAQ Proteomic Technology 105
Human IL-10 Producing T Cells Specific for Mycobacterium tuberculosis. 105
Dissecting the role of mesenchymal stem cells in idiopathic pulmonary fibrosis: cause or solution? 105
Etiology and Level of Lung Derangement Do Not Affect the Beneficial Effect of Pulmonary Rehabilitation in Patients with Interstitial Lung Diseases 104
Fibrotic idiopathic interstitial lung disease: the molecular and cellular key players. 104
Tubercolosi 101
Infezioni sistemiche a prevalente localizzazione polmonare 100
Inspiratory effort and respiratory mechanics in spontaneously breathing patients with acute exacerbation of idiopathic pulmonary fibrosis: a retrospective matched control study. 98
Totale 19.732
Categoria #
all - tutte 78.521
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 78.521


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.675 0 0 168 258 430 614 640 456 440 229 264 176
2020/20213.590 362 191 267 312 361 311 320 362 211 404 264 225
2021/20222.947 229 293 156 210 142 187 146 156 332 226 495 375
2022/20233.613 349 340 237 313 360 424 166 381 428 144 260 211
2023/20243.644 172 201 235 342 471 373 470 407 127 145 305 396
2024/2025625 315 177 133 0 0 0 0 0 0 0 0 0
Totale 21.552